Background The primary goal of human papillomavirus (HPV) vaccination is to reduce
morbidity and mortality from HPV-associated disease, especially cervical cancer. We …

A single dose of human papillomavirus (HPV) vaccine against HPV infection (prerequisite
for cervical cancer) appears to be as efficacious as two or three doses, despite inducing …

Background Human papillomavirus (HPV) vaccines were first licensed as a three-dose
series. Two doses are now widely recommended in some age groups; there are data …

Human papillomavirus (HPV) vaccines work by preventing infections prior to natural
exposure. Thus, it is likely more effective at younger ages, and it is important to understand …

Abstract Background In 2009, Norway initiated routine quadrivalent HPV (qHPV) vaccination
for girls at 12–13 years of age to protect against virus types causing cervical cancer …

The human papilloma virus (HPV) is responsible for different pathological manifestations in
humans. This agent gives rise to lesions of different types and in different areas of the …

Human papillomavirus (HPV) is the most prevalent sexually transmitted infection among
young women. Notably, more than ten years after the introduction of HPV vaccination …

During pregnancy, hormonal and immune adaptations are vital for supporting the genetically
distinct fetus during elevated infection risks. The global prevalence of HPV necessitates its …

The World Health Organization Call to Eliminate Cervical Cancer resonates in cities like
Manaus, Brazil, where the burden is among the world's highest. Manaus has offered free …

3. Mecklenburg I, Reznik D, Fasler-Kan E, et al. Serum hepcidin concentrations correlate
with ferritin in patients with inflammatory bowel disease. J Crohns Colitis. 2014; 8 (11): 1392 …